ISSUE OF EUA VACCINE SINOVAC

Head of POM Penny K. Lukito provides an issue of use approval in emergency or Emergency Use Authorization (EUA) for COVID-19 Vaccine in the POM Body Office, Jakarta, Monday (11/1/2021). The POM body issued the EUA issuer for the Coronavac vaccine produced by Sinovac Biotech with a vaccine efficacy of 65,3 percent based on the results of the clinic test in Bandung. ANTARA PHOTO/HO/Humas BPOM/wpa/hp.

The caption is automatically translated by application. Click here for the Bahasa Indonesia version.